Schniertshauer Daniel, Wespel Susanne, Bergemann Jörg
Department of Life Sciences, Albstadt-Sigmaringen University of Applied Sciences, Anton-Günther-Str. 51, 72488 Sigmaringen, Germany.
Curr Issues Mol Biol. 2023 May 2;45(5):3911-3932. doi: 10.3390/cimb45050250.
Based on the knowledge that many diseases are caused by defects in the metabolism of the cells and, in particular, in defects of the mitochondria, mitochondrial medicine starts precisely at this point. This new form of therapy is used in numerous fields of human medicine and has become a central focus within the field of medicine in recent years. With this form of therapy, the disturbed cellular energy metabolism and an out-of-balance antioxidant system of the patient are to be influenced to a greater extent. The most important tool here is mitotropic substances, with the help of which attempts are made to compensate for existing dysfunction. In this article, both mitotropic substances and accompanying studies showing their efficacy are summarized. It appears that the action of many mitotropic substances is based on two important properties. First, on the property of acting antioxidantly, both directly as antioxidants and via activation of downstream enzymes and signaling pathways of the antioxidant system, and second, via enhanced transport of electrons and protons in the mitochondrial respiratory chain.
基于许多疾病是由细胞代谢缺陷,尤其是线粒体缺陷引起的这一认识,线粒体医学正是从这一点开始的。这种新的治疗形式应用于人类医学的众多领域,并且近年来已成为医学领域的核心焦点。通过这种治疗形式,患者紊乱的细胞能量代谢和失衡的抗氧化系统将在更大程度上受到影响。这里最重要的工具是亲线粒体物质,借助它来尝试弥补现有的功能障碍。在本文中,亲线粒体物质以及显示其功效的相关研究都进行了总结。许多亲线粒体物质的作用似乎基于两个重要特性。第一,作为抗氧化剂直接发挥抗氧化作用,以及通过激活抗氧化系统的下游酶和信号通路来发挥抗氧化作用;第二,通过增强线粒体呼吸链中电子和质子的转运。